Two-Step Diagnostic Framework Outperforms Body Mass Index in Assessing Obesity Risks

A new diagnostic definition of obesity outperforms body mass index in identifying meaningful differences in individual health and long-term prognosis, including mortality risk, according to a large international study published in Nature. Led by researchers at King’s College London, the investigation evaluated a diagnostic framework originally proposed by a Lancet Diabetes & Endocrinology Commission in January 2025. The international validation study was designed to respond to growing medical concerns that relying exclusively on standard body mass index assessments has contributed to the clinical misdiagnosis of millions of individuals worldwide.

Standard body mass index calculations fail to accurately reflect an individual’s total body-fat amount or anatomical distribution, both of which strongly influence metabolic and cardiovascular health risks. Furthermore, body mass index does not measure physiological effects on organ function, leaving clinicians unable to reliably distinguish active illness from preserved health using height and weight measurements alone. The newly validated framework was engineered to improve the clinical identification of excess body fat while differentiating clinical obesity from pre-clinical obesity based on measurable impacts on organ function and daily activities.

The diagnostic framework proposed by the Lancet Commission operates through a sequential two-step assessment protocol. In the initial step, clinicians complement traditional body mass index assessments with anatomical measurements such as waist circumference and waist-to-height ratio to definitively verify excess body fat. The second step categorizes confirmed cases into two distinct stages: clinical obesity, defined as an active disease state in which excess body fat impairs organ function, and pre-clinical obesity, characterized by excess adipose tissue that elevates future health risks while organ and whole-body functions remain preserved.

To test this diagnostic model, investigators evaluated health records from 844,108 adults across China, the United Kingdom, the United States, and Spain, directly comparing standard body mass index classifications against the new two-step framework. The research was conducted through an international collaboration involving King’s College London, Huazhong University of Science and Technology, Kailuan General Hospital, North China University of Science and Technology, Pennington Biomedical Research Center, the University of Colorado Anschutz, the University of Girona, and Università Cattolica del Sacro Cuore. To separate organ dysfunction directly attributable to obesity from medical conditions arising from other causes, the authors applied a statistical methodology accounting for the background risk of organ dysfunction observed among individuals without obesity.

The findings demonstrated that relying on body mass index alone resulted in misclassifications in both directions across the international cohorts. Adding waist measurements revealed that standard body mass index assessments missed obesity-level body fat in up to 8.6 percent of participants, while incorrectly categorizing up to 3.1 percent of non-obese individuals as having obesity. Crucially, obesity was associated with an elevated risk of death only when cases were confirmed by pairing waist measurements with body mass index, rather than relying on body mass index values in isolation.

Within the study population, clinical obesity represented between 23 percent and 31 percent of all confirmed obesity cases, corresponding to an overall prevalence of 5.6 percent to 10.9 percent across the broader population. Patients diagnosed with clinical obesity experienced a substantially higher risk of death, whereas pre-clinical obesity was associated with only a modest elevation in risk. Long-term tracking revealed that the vast majority of individuals with pre-clinical obesity—ranging from 77 percent to 91 percent across the examined study cohorts—did not progress to clinical obesity over a ten-year observation period.

Senior study author Professor Francesco Rubino, chair of Metabolic and Bariatric Surgery at King’s College London and honorary consultant surgeon at King’s College Hospital, highlighted that up to one-third of all obesity cases meet the threshold for active clinical disease. Rubino noted that because most individuals with pre-clinical obesity remained free of clinical organ impairment for a decade, pre-clinical cases should neither be treated automatically as an active illness nor dismissed as harmless, advocating instead for preventive therapies calibrated to individual risk profiles. Rubino added that uniform body mass index thresholds prevent personalized care and leave patients vulnerable to overtreatment or undertreatment, whereas matching care intensity to verified health needs ensures appropriate management for both patients and health systems.

First author Professor An Pan, from Huazhong University of Science and Technology in Wuhan, China, emphasized that rapid advances in available treatments make a clinically grounded diagnosis vital for directing proportionate medical care. Pan noted that the marked differences in prognosis identified between clinical and pre-clinical obesity were consistently observed across distinct countries and ethnic groups, supporting global adoption of the framework to guide public health policy and clinical practice. By moving beyond isolated height and weight ratios, the new framework shifts one of medicine’s most contentious debates away from whether obesity constitutes a disease to determining precisely when it represents active disease in an individual.

Subject of Research: Diagnostic validation of a two-step clinical and pre-clinical obesity framework

Article Title: New clinical definition outperforms BMI in diagnosing obesity

Article References: New clinical definition outperforms BMI in diagnosing obesity. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: clinical obesity, pre-clinical obesity, body mass index, waist circumference, waist-to-height ratio, organ dysfunction, mortality risk, King's College London, Lancet Commission, Huazhong University of Science and Technology, Nature journal, obesity diagnosis, body fat distribution, disease staging, preventive medicine, prognostic validation, global cohort study